Mark Berger

Insider Reports History

Entity
Individual
Location
140 Riverside Drive, Apt. 9 K, New York, NY
Signature
/s/ Mark Berger
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Berger:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Genprex, Inc. Chief Medical Officer Common Stock 4.81K $258K $1.06 Feb 18, 2024 Direct
Actinium Pharmaceuticals, Inc. Chief Medical Officer Stock Option (Right to Buy) 67.2K Sep 1, 2021 Direct

Insider Reports Filed by Mark Berger

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GNPX Genprex, Inc. Feb 18, 2024 1 -$5.8K 4 Feb 21, 2024 Chief Medical Officer
GNPX Genprex, Inc. Feb 18, 2023 1 $0 4 Feb 22, 2023 Chief Medical Officer
GNPX Genprex, Inc. Feb 4, 2022 1 $0 4 Feb 8, 2022 Chief Medical Officer
GNPX Genprex, Inc. Sep 27, 2021 1 $0 4 Sep 28, 2021 Chief Medical Officer
GNPX Genprex, Inc. Sep 27, 2021 0 $0 3 Sep 28, 2021 Chief Medical Officer
ATNM Actinium Pharmaceuticals, Inc. Sep 1, 2021 1 $0 4 Sep 3, 2021 Chief Medical Officer